AIRAscore structure

AIRAmed

AIRAscore structure provides quantitative data of brain tissue and brain structures for early detection of atrophies and tracking progression. In addition, the lesion characterisation and quantification may support the diagnosis of a wide range of neurodegenerative diseases. The results are presented in the PACS as a PDF report and compared to an age- and sex-correlated reference collective. Bar charts and a pictogram-based spatial representation of the results facilitate their interpretation.

Information source: Vendor
Last updated: September 29, 2023

General Information

General
Product name	AIRAscore structure
Company	AIRAmed
Subspeciality	Neuro
Modality	MR
Disease targeted	Neurodegenerative diseases, e.g. dementia, Alzheimer’s disease, multiple sclerosis, Parkinson’s Disease
Key-features	Brain tissue and anatomy segmentation, volume quantification, normative comparison, report generation, WMH detection and quantification
Suggested use	During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand)

Technical Specifications

Data characteristics
Population	All with suspicion of or in treatment of neurodegenerative disease
Input	3DT1 MRI, 3D or 2D T2 FLAIR, 1.5 or 3T
Input format	DICOM
Output	Table of quantified values, bar charts and a pictogram-based spatial representation of the values, PDF-report, segmentation overlays
Output format	DICOM, DICOM-PDF
Technology
Integration	Integration in standard reading environment (PACS)
Deployment	Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution
Trigger for analysis	On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time	1 - 10 minutes

Regulatory

Certification
CE	Certified, Class I , MDD
FDA	510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)

Market

Market presence
On market since	08-2020
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model	Pay-per-use
Based on	Number of analyses

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers